×
About 34,068 results

ALLMedicine™ Thyroid Cancer Center

Research & Reviews  15,767 results

Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer.
https://doi.org/10.1016/j.critrevonc.2021.103366
Critical Reviews in Oncology/hematology; Fogli S, Gianfilippo G et. al.

May 29th, 2021 - Lenvatinib is a non-selective tyrosine kinase inhibitor with high in vitro potency against vascular endothelial growth factor receptors. Although this drug is used to treat several cancer types, it is the most effective TKI used in patients with t...

FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid cancers with RE...
https://doi.org/10.1158/1078-0432.CCR-21-0967
Clinical Cancer Research : an Official Journal of the Ame... Kim J, Bradford D et. al.

May 28th, 2021 - The FDA granted accelerated approval for pralsetinib on September 4 for NSCLC and December 1, 2020 for thyroid cancer, for: 1) adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), 2) adult and pediatric patients {...

see more →

Guidelines  89 results

Pralsetinib Shows Clinical Activity in Multiple RET Fusion–Positive Tumors
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200186/full/

May 28th, 2020 - The investigational RET inhibitor pralsetinib (BLU-667) has demonstrated durable activity, regardless of RET fusion genotype, in multiple advanced solid tumor types, according to data from the phase I/II ARROW trial (Abstract 109). Earlier analyse...

The revised clinical practice guidelines on the management of thyroid tumors by the Jap...
https://doi.org/10.1507/endocrj.EJ20-0025
Endocrine Journal; Ito Y, Onoda N et. al.

Apr 9th, 2020 - The Japan Associations of Endocrine Surgeons has developed the revised version of the Clinical Practice Guidelines for Thyroid Tumors. This article describes the guidelines translated into English for the 35 clinical questions relevant to the ther...

Childhood Thyroid Cancer Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/thyroid/hp/child-thyroid-treatment-pdq

Aug 15th, 2019 - Treatment for children with thyroid cancer depends on the type (follicular, papillary, medullary) and may include surgery or radioactive iodine ablation. Targeted therapy may be used in advanced disease. Get detailed treatment information for chil...

Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiate...
https://doi.org/10.1089/thy.2018.0597
Thyroid : Official Journal of the American Thyroid Associ... Tuttle RM, Ahuja S et. al.

Mar 22nd, 2019 - Publication of the 2015 American Thyroid Association (ATA) management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer was met with disagreement by the extended nuclear medicine community with regard to some of ...

Cancer incidence in the Agricultural Health Study after 20 years of follow-up
https://link.springer.com/article/10.1007%2Fs10552-019-01140-y
Cancer Causes & Control; Lerro,C.,et al

Feb 24th, 2019 - To evaluate cancer incidence in the Agricultural Health Study (AHS), a cohort of private pesticide applicators, their spouses, and commercial applicators, based on 12,420 cancers, adding 5,989 cancers, and 9 years of follow-up since last evaluatio...

see more →

Drugs  259 results see all →

Clinicaltrials.gov  17,001 results

Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer.
https://doi.org/10.1016/j.critrevonc.2021.103366
Critical Reviews in Oncology/hematology; Fogli S, Gianfilippo G et. al.

May 29th, 2021 - Lenvatinib is a non-selective tyrosine kinase inhibitor with high in vitro potency against vascular endothelial growth factor receptors. Although this drug is used to treat several cancer types, it is the most effective TKI used in patients with t...

FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid cancers with RE...
https://doi.org/10.1158/1078-0432.CCR-21-0967
Clinical Cancer Research : an Official Journal of the Ame... Kim J, Bradford D et. al.

May 28th, 2021 - The FDA granted accelerated approval for pralsetinib on September 4 for NSCLC and December 1, 2020 for thyroid cancer, for: 1) adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), 2) adult and pediatric patients {...

see more →

News  919 results

A New Frontier in Papillary Thyroid Cancer Treatment
https://www.medscape.com/viewarticle/949688

Apr 25th, 2021 - A 73-year-old man with prostate cancer and hypertension came to see me for an incidental diagnosis of papillary thyroid microcarcinoma (PTMC). He had undergone fluorodeoxyglucose (FDG) PET with his oncology team because of a rising serum prostate-...

Low-Risk Thyroid Cancer: No Benefit of Postsurgical Iodine
https://www.medscape.com/viewarticle/948970

Apr 7th, 2021 - After 3 years of follow-up in patients with low-risk differentiated thyroid cancer (DTC), there is no significant difference in the rate of tumor-related events in those treated with postsurgical radioactive iodine (RAI) relative to those who are ...

Increase in Thyroid Cancer Rates Points to Overscreening
https://www.medscape.com/viewarticle/947416

Mar 14th, 2021 - The incidence of thyroid cancer cases has increased markedly since the late 1990s, although rates vary widely between countries, and the increases have been largely confined to the papillary subtype, suggests a new population-based study spanning ...

Fukushima Radiation Unlikely to Raise Cancer Rates, UN Experts Say
https://www.medscape.com/viewarticle/947117

Mar 9th, 2021 - VIENNA (Reuters) - A U.N. scientific panel on Tuesday confirmed a previous finding that radiation from the 2011 Fukushima disaster in Japan was unlikely to raise cancer rates discernibly, and said a jump in thyroid cancer in children was due to "u...

Nighttime Artificial Light Linked to Increased Thyroid Cancer Risk
https://www.medscape.com/viewarticle/945579

Feb 9th, 2021 - People living in regions with high levels of outdoor artificial light at night may face a higher risk of developing thyroid cancer, according to the finding of a study published in the journal Cancer. Among 464,371 American adults aged 50 to 71 ye...

see more →

Patient Education  33 results see all →